Laboratory Corporation of America Holdings, an S&P 500 company, is a leading global life sciences company that is deeply integrated in guiding patient care, providing comprehensive clinical laboratory & end-to-end drug development services. With a mission to improve health and improve lives, LabCorp delivers world-class diagnostic solutions, brings innovative medicines to patients faster and uses technology to provide better care. It also provides specialty testing services in the areas of women's health, allergy, diagnostic genetics, cardiovascular disease, infectious disease, endocrinology, oncology, coagulation, pharmacogenetics, toxicology & pain management; and esoteric testing, cancer diagnostics, and other complex procedures. In addition, the company provides drug development solutions, as well as laboratory testing services. Further, it provides its testing services through a sales force to the managed care organizations, biopharmaceutical companies, physicians and other healthcare providers etc.
Industry sector: Medical
Sector classification: Medical laboratories
Deep Learning based analysis and prediction model for Laboratory Corporation of America Holdings (LH) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.
Model is in the production pipeline since Oct. 22, 2015.
Market data for LH model training are being downloaded from the Quandl premium datasets on a daily basis.
Model is being retrained on a daily basis.
|% Held by Insiders||0.90%|
|% Held by Institutions||91.46%|
|EPS (last reported FY)||$8.83|
|EPS (last reported Q)||$2.46|
|EPS, estimated (last reported Q)||$2.38|
|Total revenues||$10 B|
|Net income||$1 B|